Latest news
Ziphius Vaccines and UZ Ghent Establish Unique Collaboration for GMP Manufacturing of saRNA-Based Vaccines
October 7, 2022
Ziphius Vaccines and UZ Ghent today announce that they have entered a public-private collaboration for the scale up and manufacturing of prophylactic self-amplifying RNA vaccines based on GMP (Good Manufacturing Practice) standards.